BIOCEPT INC Annual Cost of Revenue in USD from 2013 to 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Biocept Inc quarterly/annual Cost of Revenue history and growth rate from 2013 to 2022.
- Biocept Inc Cost of Revenue for the quarter ending June 30, 2023 was $2.55M, a 68.2% decline year-over-year.
- Biocept Inc Cost of Revenue for the twelve months ending June 30, 2023 was $15.7M, a 60.5% decline year-over-year.
- Biocept Inc annual Cost of Revenue for 2022 was $28.4M, a 24.7% decline from 2021.
- Biocept Inc annual Cost of Revenue for 2021 was $37.8M, a 77% increase from 2020.
- Biocept Inc annual Cost of Revenue for 2020 was $21.3M, a 94.4% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)